Ponatinib Averts αCD40 Antibody Mediated Toxicity by Lowering MAPK38 Expression and Shows Proimmunogenic Effects in a Murine Tumor Model

Ponatinib通过降低MAPK38表达来避免αCD40抗体介导的毒性，并在小鼠肿瘤模型中显示出促免疫原性作用。